$ARDX
ARDELYX, INC.

2020 Q4 Form 10-K Financial Statement

#000155837021002500 Filed on March 08, 2021

View on sec.gov

Income Statement

Concept 2020 Q4 2019 Q4 2019 Q3
Revenue $1.809M $2.250M $3.013M
YoY Change -19.6% 2400.0% 1672.35%
Cost Of Revenue $0.00 $0.00 $600.0K
YoY Change
Gross Profit $1.810M $2.250M $2.413M
YoY Change -19.56% 2400.0% 1319.41%
Gross Profit Margin 100.06% 100.0% 80.09%
Selling, General & Admin $11.34M $6.860M $6.920M
YoY Change 65.31% 26.34% 16.11%
% of Gross Profit 626.52% 304.89% 286.78%
Research & Development $18.11M $14.24M $17.58M
YoY Change 27.18% -35.39% -2.01%
% of Gross Profit 1000.55% 632.89% 728.55%
Depreciation & Amortization $420.0K $510.0K $640.0K
YoY Change -17.65% -23.88% -4.48%
% of Gross Profit 23.2% 22.67% 26.52%
Operating Expenses $29.45M $21.10M $17.58M
YoY Change 39.57% -23.16% -26.44%
Operating Profit -$27.64M -$18.85M -$22.09M
YoY Change 46.63% -31.13% -6.92%
Interest Expense -$1.310M -$1.400M $1.443M
YoY Change -6.43% -60.34%
% of Operating Profit
Other Income/Expense, Net $80.00K $460.0K $294.0K
YoY Change -82.61% -84.92% -175.38%
Pretax Income -$28.87M -$19.79M -$23.24M
YoY Change 45.88% -28.97% -3.7%
Income Tax $0.00 $0.00 $301.0K
% Of Pretax Income
Net Earnings -$28.88M -$19.79M -$23.54M
YoY Change 45.91% -28.97% -2.45%
Net Earnings / Revenue -1596.24% -879.56% -781.25%
Basic Earnings Per Share
Diluted Earnings Per Share -$317.4K -$283.2K -$374.7K
COMMON SHARES
Basic Shares Outstanding 90.25M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q4 2019 Q4 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $186.5M $247.5M $103.5M
YoY Change -24.66% 47.24% -44.47%
Cash & Equivalents $91.03M $181.1M $92.67M
Short-Term Investments $95.45M $66.38M $10.90M
Other Short-Term Assets $8.200M $3.800M $4.600M
YoY Change 115.79% 18.75% -40.26%
Inventory
Prepaid Expenses
Receivables $0.00 $800.0K $2.700M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $194.7M $252.1M $110.8M
YoY Change -22.76% 42.89% -44.41%
LONG-TERM ASSETS
Property, Plant & Equipment $1.936M $3.436M $8.400M
YoY Change -43.66% -38.76% 40.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $2.100M
YoY Change
Other Assets $552.0K $314.0K $200.0K
YoY Change 75.8% -76.74% -85.71%
Total Long-Term Assets $6.876M $7.720M $8.600M
YoY Change -10.93% 11.37% 16.22%
TOTAL ASSETS
Total Short-Term Assets $194.7M $252.1M $110.8M
Total Long-Term Assets $6.876M $7.720M $8.600M
Total Assets $201.6M $259.8M $119.4M
YoY Change -22.41% 41.7% -42.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.626M $2.187M $2.700M
YoY Change 157.25% 90.51% 17.39%
Accrued Expenses $12.80M $12.60M $14.00M
YoY Change 1.59% -13.7% 30.84%
Deferred Revenue $4.177M
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $4.200M $1.200M
YoY Change 250.0%
Total Short-Term Liabilities $28.42M $22.22M $17.70M
YoY Change 27.88% 25.34% 14.19%
LONG-TERM LIABILITIES
Long-Term Debt $46.60M $48.80M $49.80M
YoY Change -4.51% -0.81% 1.63%
Other Long-Term Liabilities $400.0K $2.100M $2.800M
YoY Change -80.95% 250.0% 300.0%
Total Long-Term Liabilities $47.00M $50.90M $52.60M
YoY Change -7.66% 2.21% 5.84%
TOTAL LIABILITIES
Total Short-Term Liabilities $28.42M $22.22M $17.70M
Total Long-Term Liabilities $47.00M $50.90M $52.60M
Total Liabilities $75.45M $73.13M $70.30M
YoY Change 3.18% 8.31% 7.82%
SHAREHOLDERS EQUITY
Retained Earnings -$554.8M -$460.5M
YoY Change 20.48% 25.97%
Common Stock $680.9M $647.1M
YoY Change 5.22% 34.43%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $126.1M $186.7M $49.16M
YoY Change
Total Liabilities & Shareholders Equity $201.6M $259.8M $119.4M
YoY Change -22.41% 41.7% -42.24%

Cashflow Statement

Concept 2020 Q4 2019 Q4 2019 Q3
OPERATING ACTIVITIES
Net Income -$28.88M -$19.79M -$23.54M
YoY Change 45.91% -28.97% -2.45%
Depreciation, Depletion And Amortization $420.0K $510.0K $640.0K
YoY Change -17.65% -23.88% -4.48%
Cash From Operating Activities -$17.59M -$11.13M -$20.62M
YoY Change 58.04% -39.61% -23.69%
INVESTING ACTIVITIES
Capital Expenditures -$250.0K $0.00 -$120.0K
YoY Change -100.0% -400.0%
Acquisitions
YoY Change
Other Investing Activities -$3.320M -$55.46M $23.56M
YoY Change -94.01% -346.71% 134.19%
Cash From Investing Activities -$3.570M -$55.46M $23.44M
YoY Change -93.56% -349.93% 132.08%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $134.9M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 21.19M 155.1M 210.0K
YoY Change -86.33% 10.53%
NET CHANGE
Cash From Operating Activities -17.59M -11.13M -20.62M
Cash From Investing Activities -3.570M -55.46M 23.44M
Cash From Financing Activities 21.19M 155.1M 210.0K
Net Change In Cash 30.00K 88.47M 3.030M
YoY Change -99.97% 2252.93% -118.11%
FREE CASH FLOW
Cash From Operating Activities -$17.59M -$11.13M -$20.62M
Capital Expenditures -$250.0K $0.00 -$120.0K
Free Cash Flow -$17.34M -$11.13M -$20.50M
YoY Change 55.8% -38.64% -24.24%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2607000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
181133000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
95452000
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020 dei Amendment Flag
AmendmentFlag
false
CY2020 dei Trading Symbol
TradingSymbol
ARDX
CY2020 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2020 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020 dei Entity Central Index Key
EntityCentralIndexKey
0001437402
CY2020 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
93599975
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
88817741
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
400000
CY2020 dei Document Type
DocumentType
10-K
CY2020 dei Document Annual Report
DocumentAnnualReport
true
CY2020 dei Document Period End Date
DocumentPeriodEndDate
2020-12-31
CY2020 dei Document Transition Report
DocumentTransitionReport
false
CY2020 dei Entity File Number
EntityFileNumber
001-36485
CY2020 dei Entity Registrant Name
EntityRegistrantName
ARDELYX, INC.
CY2020 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-1303944
CY2020 dei Entity Address Address Line1
EntityAddressAddressLine1
34175 ARDENWOOD BLVD.
CY2020 dei Entity Address City Or Town
EntityAddressCityOrTown
FREMONT
CY2020 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94555
CY2020 dei City Area Code
CityAreaCode
510
CY2020 dei Local Phone Number
LocalPhoneNumber
745-1700
CY2020 dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
CY2020 dei Trading Symbol
TradingSymbol
ARDX
CY2020 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2020 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2020 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2020 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2020 dei Entity Small Business
EntitySmallBusiness
true
CY2020 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020 ardx Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2019Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
66379000
CY2019Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
750000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8202000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3800000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
194686000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
252062000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1936000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3436000
CY2020Q4 us-gaap Long Term Investments
LongTermInvestments
2114000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2274000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3970000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
552000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
314000
CY2020Q4 us-gaap Assets
Assets
201562000
CY2019Q4 us-gaap Assets
Assets
259782000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5626000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2187000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5672000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4453000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2117000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2608000
CY2020Q4 us-gaap Loans Payable Current
LoansPayableCurrent
4167000
CY2019Q4 us-gaap Loans Payable Current
LoansPayableCurrent
1183000
CY2020Q4 us-gaap Deferred Revenue
DeferredRevenue
4177000
CY2019Q4 us-gaap Deferred Revenue
DeferredRevenue
4541000
CY2020Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
6657000
CY2019Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
7248000
CY2020 us-gaap Cost Of Revenue
CostOfRevenue
145000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
28416000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
22220000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
413000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2076000
CY2020Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
46621000
CY2019Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
48831000
CY2020Q4 us-gaap Liabilities
Liabilities
75450000
CY2019Q4 us-gaap Liabilities
Liabilities
73127000
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2019 us-gaap Cost Of Revenue
CostOfRevenue
600000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
93599975
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
88817741
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
9000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
9000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
680872000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
647078000
CY2020 dei Entity Shell Company
EntityShellCompany
false
CY2020Q2 dei Entity Public Float
EntityPublicFloat
611732242
CY2021Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
98680264
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
91032000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-554765000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-460452000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
20000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
126112000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
186655000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
201562000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
259782000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7571000
CY2018 us-gaap Cost Of Revenue
CostOfRevenue
466000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5281000
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
65053000
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
71677000
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
69373000
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
33153000
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
24267000
CY2018 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
23715000
CY2020 us-gaap Costs And Expenses
CostsAndExpenses
98351000
CY2019 us-gaap Costs And Expenses
CostsAndExpenses
96544000
CY2018 us-gaap Costs And Expenses
CostsAndExpenses
93554000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-90780000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-91263000
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-90947000
CY2020 us-gaap Interest Expense
InterestExpense
5099000
CY2019 us-gaap Interest Expense
InterestExpense
5726000
CY2018 us-gaap Interest Expense
InterestExpense
3534000
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1568000
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2352000
CY2018 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3187000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-94311000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-94637000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-91294000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
303000
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-94313000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-94940000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-91298000
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.05
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.47
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.62
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
89582138
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
64478066
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
56219919
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-94313000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-94940000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-91298000
CY2020 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-24000
CY2019 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
58000
CY2018 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
9000
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-94337000
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-94882000
CY2018 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-91289000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
139312000
CY2018Q4 us-gaap Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
4000000
CY2018 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
491000
CY2018 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
303000
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9226000
CY2018 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
9000
CY2018 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
53770000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-91298000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
115813000
CY2019 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
396000
CY2019 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
312000
CY2019 ardx Non Cash Lease Expense
NonCashLeaseExpense
1839000
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
178000
CY2019 ardx Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-1892000
CY2020 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1000000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9936000
CY2019 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
58000
CY2019 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-5861000
CY2018 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1353000
CY2020 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-364000
CY2019 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
4541000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-94940000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
186655000
CY2020 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
834000
CY2020 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
310000
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1020000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10583000
CY2020 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-24000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-94313000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
126112000
CY2020 us-gaap Profit Loss
ProfitLoss
-94313000
CY2019 us-gaap Profit Loss
ProfitLoss
-94940000
CY2018 us-gaap Profit Loss
ProfitLoss
-91298000
CY2020 us-gaap Depreciation
Depreciation
1824000
CY2019 us-gaap Depreciation
Depreciation
2501000
CY2018 us-gaap Depreciation
Depreciation
2678000
CY2020 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
496000
CY2019 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
670000
CY2018 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
236000
CY2020 ardx Amortization Of Deferred Compensation Expense
AmortizationOfDeferredCompensationExpense
313000
CY2019 ardx Amortization Of Deferred Compensation Expense
AmortizationOfDeferredCompensationExpense
309000
CY2018 ardx Amortization Of Deferred Compensation Expense
AmortizationOfDeferredCompensationExpense
253000
CY2020 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
92000
CY2019 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
698000
CY2018 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
1136000
CY2020 ardx Non Cash Lease Expense
NonCashLeaseExpense
2147000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
10583000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
9936000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
9226000
CY2020 us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
407000
CY2019 us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
436000
CY2018 us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
111000
CY2020 ardx Noncash Interest Expense
NoncashInterestExpense
413000
CY2019 ardx Noncash Interest Expense
NoncashInterestExpense
478000
CY2018 ardx Noncash Interest Expense
NoncashInterestExpense
303000
CY2020 ardx Increase Decrease In Unbilled Revenue
IncreaseDecreaseInUnbilledRevenue
-750000
CY2019 ardx Increase Decrease In Unbilled Revenue
IncreaseDecreaseInUnbilledRevenue
-4250000
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-85000
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-10711000
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4653000
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-93000
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-525000
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3439000
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
39000
CY2018 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2730000
CY2020 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
1219000
CY2019 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
1730000
CY2018 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-506000
CY2020 ardx Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-2604000
CY2018 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
169033000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
324000
CY2018 us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
49292000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
22776000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
155476000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
103553000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-90101000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
102365000
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
3385000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-81435000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-76484000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-70274000
CY2020 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
119734000
CY2019 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
126369000
CY2018 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
139450000
CY2020 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
150852000
CY2019 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
102671000
CY2019 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
574000
CY2018 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
491000
CY2020 us-gaap Repayments Of Debt
RepaymentsOfDebt
125000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
325000
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
311000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-31442000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
23373000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-29894000
CY2019 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
134927000
CY2018 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
53770000
CY2019 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
19975000
CY2020 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1854000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
181133000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
78768000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
75383000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
91032000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
181133000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
78768000
CY2020 us-gaap Interest Paid Net
InterestPaidNet
4200000
CY2019 us-gaap Interest Paid Net
InterestPaidNet
4920000
CY2018 us-gaap Interest Paid Net
InterestPaidNet
3071000
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1000
CY2019 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2000
CY2018 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4000
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
450000
CY2019 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
5810000
CY2020 us-gaap Stock Issued1
StockIssued1
310000
CY2019 us-gaap Stock Issued1
StockIssued1
312000
CY2018 us-gaap Stock Issued1
StockIssued1
303000
CY2018 ardx Issuance Of Derivative In Connection With Issuance Of Loan Payable
IssuanceOfDerivativeInConnectionWithIssuanceOfLoanPayable
546000
CY2020 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2020 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and judgments that affect the amounts reported in the financial statements and accompanying notes. On an ongoing basis, management evaluates its estimates, including those related to recognition of revenue, clinical trial accruals, contract manufacturing accruals, fair value of assets and liabilities, income taxes and stock-based compensation. Management bases its estimates on historical experience and on various other market-specific and relevant assumptions that management believes to be reasonable under the circumstances. Actual results could materially differ from those estimates. </p>
CY2020Q4 us-gaap Investments And Cash
InvestmentsAndCash
188600000
CY2020 ardx Cash And Cash Equivalents Original Maturity Dates
CashAndCashEquivalentsOriginalMaturityDates
P90D
CY2020 ardx Short Term Investments Maturity Period Description
ShortTermInvestmentsMaturityPeriodDescription
Short-term investments consist of debt securities classified as available-for-sale and have maturities greater than 90 days, but less than one year, from the date of acquisition.
CY2020 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Concentration of Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash, cash equivalents, short-term investments and accounts receivable. The Company is exposed to credit risks in the event of default by the counterparties to the extent of the amount recorded in its balance sheet. Cash, cash equivalents and short-term investments are invested through banks and other financial institutions in the U.S. </p>
CY2018 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2019 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2020 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2020 us-gaap Derivatives Reporting Of Derivative Activity
DerivativesReportingOfDerivativeActivity
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Derivatives and Hedging Activities</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company accounts for its derivative instruments as either assets or liabilities on the balance sheet and measures them at fair value. Derivatives are adjusted to fair value through other income (expense), net in the statements of operations and comprehensive loss. </p>
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
91032000
CY2020Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
91032000
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
95455000
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
7000
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
10000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
95452000
CY2020Q4 us-gaap Investments And Cash
InvestmentsAndCash
188602000
CY2020Q4 ardx Cash Cash Equivalents And Investments Gross Unrealized Gains
CashCashEquivalentsAndInvestmentsGrossUnrealizedGains
7000
CY2020Q4 ardx Cash Cash Equivalents And Investments Gross Unrealized Losses
CashCashEquivalentsAndInvestmentsGrossUnrealizedLosses
11000
CY2020Q4 ardx Cash Cash Equivalents And Investments Fair Value Disclosure
CashCashEquivalentsAndInvestmentsFairValueDisclosure
188598000
CY2019Q4 us-gaap Other Cash Equivalents At Carrying Value
OtherCashEquivalentsAtCarryingValue
181130000
CY2019Q4 ardx Cash And Cash Equivalents Gross Unrealized Gains
CashAndCashEquivalentsGrossUnrealizedGains
3000
CY2019Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
181133000
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
66362000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
20000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
3000
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
66379000
CY2019Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
247492000
CY2019Q4 ardx Cash Cash Equivalents And Short Term Investments Gross Unrealized Gains
CashCashEquivalentsAndShortTermInvestmentsGrossUnrealizedGains
23000
CY2019Q4 ardx Cash Cash Equivalents And Short Term Investments Gross Unrealized Losses
CashCashEquivalentsAndShortTermInvestmentsGrossUnrealizedLosses
3000
CY2019Q4 ardx Cash Cash Equivalents And Short Term Investments Fair Value Disclosure
CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure
247512000
CY2019Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
95455000
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
95452000
CY2020Q4 ardx Debt Securities Available For Sale Amortized Cost Maturity Allocated And Single Maturity Date After Year One Through Two
DebtSecuritiesAvailableForSaleAmortizedCostMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughTwo
2115000
CY2020Q4 ardx Debt Securities Available For Sale Fair Value Maturity Allocated And Single Maturity Date After Year One Through Five
DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughFive
2114000
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
97570000
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
97566000
CY2018Q2 us-gaap Business Exit Costs1
BusinessExitCosts1
1500000
CY2020Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
1376000000
CY2019Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
969000000
CY2018Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
533000000
CY2020 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
407000000
CY2019 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
436000000
CY2018 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
533000000
CY2019Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
969000000
CY2018Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
533000000
CY2018Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
50000000.0
CY2018Q2 us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
49300000
CY2020Q4 ardx Debt Instrument Interest Payment Extension Term
DebtInstrumentInterestPaymentExtensionTerm
P12M
CY2018Q2 ardx Debt Instrument Interest Payment Extension Term
DebtInstrumentInterestPaymentExtensionTerm
P6M
CY2020Q4 ardx Debt Instrument Interest Payment Extension Term
DebtInstrumentInterestPaymentExtensionTerm
P12M
CY2018Q2 ardx Fee Payable Upon Closing Of Term Loan
FeePayableUponClosingOfTermLoan
500000
CY2020Q4 ardx Fee Payable Upon Closing Of Term Loan
FeePayableUponClosingOfTermLoan
100000
CY2018Q2 ardx Default Interest Rate
DefaultInterestRate
0.040
CY2020Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
4167000
CY2020Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
48308000
CY2020Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
52475000
CY2020Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
518000
CY2020Q4 ardx Debt Instrument Unaccreted Value Final Fee
DebtInstrumentUnaccretedValueFinalFee
1169000
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
50788000
CY2020Q4 us-gaap Loans Payable Current
LoansPayableCurrent
4167000
CY2020Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
46621000
CY2020Q3 ardx Maximum Aggregate Offering Price
MaximumAggregateOfferingPrice
250000000.0
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
3300000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
21700000
ardx Weighted Average Share Price
WeightedAverageSharePrice
6.65
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
8200000
CY2015Q2 ardx Warrant Term
WarrantTerm
P5Y
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
445942
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.29
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
56700000
ardx Weighted Average Share Price
WeightedAverageSharePrice
6.91
CY2020 ardx Stock Issuance Cost Commission Percent
StockIssuanceCostCommissionPercent
0.030
CY2019Q4 us-gaap Share Price
SharePrice
6.25
CY2015Q2 ardx Warrants Exercised In Period
WarrantsExercisedInPeriod
0
CY2020 ardx Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Options Exercised In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsExercisedInPeriod
0
CY2015Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
13.91
CY2019Q4 ardx Proceeds From Issuance Of Common Stock Gross
ProceedsFromIssuanceOfCommonStockGross
143800000
CY2019Q4 ardx Underwriting Discounts And Commissions
UnderwritingDiscountsAndCommissions
8900000
CY2019Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
134900000
CY2018Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14.4
CY2015Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
2200000
CY2015Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.125
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
CY2014Q2 us-gaap Deferred Compensation Arrangement With Individual Common Stock Reserved For Future Issuance
DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance
1500000
CY2014Q2 ardx Increase In Shares Reserved For Issuance Maximum Shares To Be Issued Up On Exercise Of Stock Options
IncreaseInSharesReservedForIssuanceMaximumSharesToBeIssuedUpOnExerciseOfStockOptions
1200000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1196746
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7272768
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.55
CY2020 ardx Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Options Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsAuthorized
3552709
CY2020 ardx Share Based Compensation Arrangement By Share Based Payment Award Options Authorized In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAuthorizedInPeriodGross
0
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3727947
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3727947
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
6.89
CY2020 us-gaap Stock Issued During Period Shares Share Based Compensation Forfeited
StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
764724
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
764724
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
8.03
CY2020 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
42403
CY2020 ardx Stock Issued During Period Shares Issued Of Services And Restricted Stock Units Net Of Forfeitures
StockIssuedDuringPeriodSharesIssuedOfServicesAndRestrictedStockUnitsNetOfForfeitures
-13229
CY2020 ardx Share Based Compensation Arrangement By Share Based Payment Award Options Issuance Of Common Stock For Services In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIssuanceOfCommonStockForServicesInPeriodGross
0
CY2020 ardx Share Based Compensation Arrangements By Share Based Payment Award Options Issuance Of Common Stock For Services In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsIssuanceOfCommonStockForServicesInPeriodWeightedAverageExercisePrice
0
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1757058
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
9790049
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.76
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y5M8D
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
12797000
CY2020Q4 ardx Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVest
9790049
CY2020Q4 ardx Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice
6.76
CY2020 ardx Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestWeightedAverageRemainingContractualTerm
P7Y5M8D
CY2020Q4 ardx Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestIntrinsicValue
12797000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
5230640
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.53
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y2M23D
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
7765000
CY2020Q4 us-gaap Equity Securities Fv Ni Measurement Input
EquitySecuritiesFvNiMeasurementInput
6.47
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
2700000
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
400000
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
0
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.82
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.79
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.29
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.83
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0107
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost
1200000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost
0
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
0
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
200000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
600000
CY2020 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
42000
CY2019 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
113000
CY2018 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
75000
CY2018 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
300000
CY2019 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
300000
CY2020 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
300000
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10583000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9936000
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9226000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
16386000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
16062000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
14450000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
12626000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1936000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3436000
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1800000
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2500000
CY2018 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2700000
CY2020Q4 ardx Accrued Clinical Expenses
AccruedClinicalExpenses
2197000
CY2019Q4 ardx Accrued Clinical Expenses
AccruedClinicalExpenses
3451000
CY2020Q4 ardx Accrued Contract Manufacturing Costs
AccruedContractManufacturingCosts
1840000
CY2019Q4 ardx Accrued Contract Manufacturing Costs
AccruedContractManufacturingCosts
1414000
CY2020Q4 ardx Derivative Liability For Exit Fee
DerivativeLiabilityForExitFee
1376000
CY2019Q4 ardx Derivative Liability For Exit Fee
DerivativeLiabilityForExitFee
969000
CY2020Q4 ardx Accrued Sales And Marketing Expenses
AccruedSalesAndMarketingExpenses
593000
CY2019Q4 ardx Accrued Sales And Marketing Expenses
AccruedSalesAndMarketingExpenses
122000
CY2020Q4 ardx Accrued Professional And Consultant Fees Current
AccruedProfessionalAndConsultantFeesCurrent
243000
CY2019Q4 ardx Accrued Professional And Consultant Fees Current
AccruedProfessionalAndConsultantFeesCurrent
201000
CY2020Q4 ardx Accrued Regulatory Services
AccruedRegulatoryServices
123000
CY2019Q4 ardx Accrued Regulatory Services
AccruedRegulatoryServices
342000
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
285000
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
749000
CY2020Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
6657000
CY2019Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
7248000
CY2020 ardx Number Of Operating Lease Arrangements
NumberOfOperatingLeaseArrangements
3
CY2016Q2 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
72500
CY2020Q4 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
10716
CY2018Q4 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
3520
CY2020Q4 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
4768
CY2020 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
400000
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.117
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y6M
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2274000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2117000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
413000
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
2530000
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y6M
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.117
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
104000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
111000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
115000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
119000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
20000
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
2608000
CY2019 us-gaap Operating Lease Cost
OperatingLeaseCost
2592000
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
3065000
CY2019 us-gaap Operating Lease Payments
OperatingLeasePayments
2645000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2280000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2749000
CY2020Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
219000
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
2530000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2117000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
413000
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
2600000
CY2019 us-gaap Operating Lease Cost
OperatingLeaseCost
2600000
CY2018 us-gaap Operating Lease Cost
OperatingLeaseCost
1800000
CY2020 ardx Collaborative Arrangement Up Front Payment And Development And Sales Milestones Payment To Be Received
CollaborativeArrangementUpFrontPaymentAndDevelopmentAndSalesMilestonesPaymentToBeReceived
19600000
CY2018 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
4000
CY2019 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
301000
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
2000
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
2000
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
2000
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
303000
CY2018 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
4000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
303000
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4000
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.223
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.219
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.225
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2020 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.013
CY2019 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.016
CY2018 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.014
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.007
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.003
CY2018 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.006
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.001
CY2019 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.009
CY2018 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.012
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.006
CY2019 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.004
CY2018 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.007
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.003
CY2020Q4 ardx Deferred Tax Assets Amortization And Depreciation
DeferredTaxAssetsAmortizationAndDepreciation
51370000
CY2019Q4 ardx Deferred Tax Assets Amortization And Depreciation
DeferredTaxAssetsAmortizationAndDepreciation
45555000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
53436000
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
40896000
CY2020Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
11777000
CY2019Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
10136000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
5524000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
4853000
CY2020Q4 ardx Deferred Tax Assets Lease Obligation
DeferredTaxAssetsLeaseObligation
1804000
CY2019Q4 ardx Deferred Tax Assets Lease Obligation
DeferredTaxAssetsLeaseObligation
984000
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
0
CY2019Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
940000
CY2019Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
28000
CY2020Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2019Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
123911000
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
103364000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
123402000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
102344000
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
509000
CY2019Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1020000
CY2020Q4 ardx Deferred Tax Liabilities Right Of Use Asset
DeferredTaxLiabilitiesRightOfUseAsset
479000
CY2019Q4 ardx Deferred Tax Liabilities Right Of Use Asset
DeferredTaxLiabilitiesRightOfUseAsset
834000
CY2020Q4 ardx Deferred Tax Liabilities Revenue Recognition
DeferredTaxLiabilitiesRevenueRecognition
0
CY2019Q4 ardx Deferred Tax Liabilities Revenue Recognition
DeferredTaxLiabilitiesRevenueRecognition
158000
CY2020Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
30000
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
24538000
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
23052000
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
20734000
CY2020 ardx Unrecognized Tax Benefits Increase Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromPriorPeriodTaxPositions
-1388000
CY2019 ardx Unrecognized Tax Benefits Increase Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromPriorPeriodTaxPositions
755000
CY2018 ardx Unrecognized Tax Benefits Increase Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromPriorPeriodTaxPositions
1634000
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
474000
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
731000
CY2018 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
684000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
23624000
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
24538000
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
23052000
CY2020Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
13300000
CY2019Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
13200000
CY2018Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
9800000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7571000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5281000
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2607000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-94313000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-94940000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-91298000
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
89582138
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
64478066
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
56219919
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.05
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.47
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.62
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10298725
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10247413
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8209246
CY2020 ardx Antidilutive Securities Included From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesIncludedFromComputationOfEarningsPerShareAmount
2100000
CY2019 ardx Antidilutive Securities Included From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesIncludedFromComputationOfEarningsPerShareAmount
1100000
CY2018 ardx Antidilutive Securities Included From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesIncludedFromComputationOfEarningsPerShareAmount
1000000.0
CY2019Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0
CY2020Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1213000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1836000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2713000
CY2020Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1809000
CY2020Q1 us-gaap Costs And Expenses
CostsAndExpenses
22982000
CY2020Q2 us-gaap Costs And Expenses
CostsAndExpenses
26043000
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
19874000
CY2020Q4 us-gaap Costs And Expenses
CostsAndExpenses
29452000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-22373000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-24956000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-18108000
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-28876000
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.25
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.28
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.20
CY2020Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.32
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18000
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3013000
CY2019Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2250000
CY2019Q1 us-gaap Costs And Expenses
CostsAndExpenses
25498000
CY2019Q2 us-gaap Costs And Expenses
CostsAndExpenses
24846000
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.37
CY2019Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.27
CY2019Q3 us-gaap Costs And Expenses
CostsAndExpenses
25102000
CY2019Q4 us-gaap Costs And Expenses
CostsAndExpenses
21098000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-26144000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-25467000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-23539000
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
-19790000
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.42
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.41

Files In Submission

Name View Source Status
0001558370-21-002500-index-headers.html Edgar Link pending
0001558370-21-002500-index.html Edgar Link pending
0001558370-21-002500.txt Edgar Link pending
0001558370-21-002500-xbrl.zip Edgar Link pending
ardx-20201231.xsd Edgar Link pending
ardx-20201231x10k.htm Edgar Link pending
ardx-20201231x10k004.jpg Edgar Link pending
ardx-20201231x10k_htm.xml Edgar Link completed
ardx-20201231xex10d31.htm Edgar Link pending
ardx-20201231xex10d31001.jpg Edgar Link pending
ardx-20201231xex10d31002.jpg Edgar Link pending
ardx-20201231xex10d31003.jpg Edgar Link pending
ardx-20201231xex10d31004.jpg Edgar Link pending
ardx-20201231xex10d31005.jpg Edgar Link pending
ardx-20201231xex10d31006.jpg Edgar Link pending
ardx-20201231xex10d31007.jpg Edgar Link pending
ardx-20201231xex10d31008.jpg Edgar Link pending
ardx-20201231xex10d31009.jpg Edgar Link pending
ardx-20201231xex10d31010.jpg Edgar Link pending
ardx-20201231xex10d31012.jpg Edgar Link pending
ardx-20201231xex10d31014.jpg Edgar Link pending
ardx-20201231xex10d31015.jpg Edgar Link pending
ardx-20201231xex10d31017.jpg Edgar Link pending
ardx-20201231xex10d31018.jpg Edgar Link pending
ardx-20201231xex10d31021.jpg Edgar Link pending
ardx-20201231xex10d31022.jpg Edgar Link pending
ardx-20201231xex10d31023.jpg Edgar Link pending
ardx-20201231xex23d1.htm Edgar Link pending
ardx-20201231xex31d1.htm Edgar Link pending
ardx-20201231xex31d2.htm Edgar Link pending
ardx-20201231xex32d1.htm Edgar Link pending
ardx-20201231xex4d4.htm Edgar Link pending
ardx-20201231_cal.xml Edgar Link unprocessable
ardx-20201231_def.xml Edgar Link unprocessable
ardx-20201231_lab.xml Edgar Link unprocessable
ardx-20201231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending